Harmony Biosciences Holdings, Inc. (HRMY) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown
HRMY's revenue distribution by segment and geography
By Geography
HRMY Revenue Analysis (2018–2025)
As of March 1, 2026, Harmony Biosciences Holdings, Inc. (HRMY) generated trailing twelve-month (TTM) revenue of $868.5 million, reflecting exceptional growth of +21.1% year-over-year. The most recent quarter (Q4 2025) recorded $243.8 million in revenue, up 1.8% sequentially.
Looking at the longer-term picture, HRMY's 5-year compound annual growth rate (CAGR) stands at +40.3%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $868.5 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including AGIO (+36.3% YoY), VRTX (+10.4% YoY), and ASND (+97.4% YoY), HRMY has underperformed the peer group in terms of revenue growth. Compare HRMY vs AGIO →
Peer Comparison
Compare HRMY's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HRMYCurrent | $868M | +21.1% | +40.3% | 24.0% | |
| AGIO | $54M | +36.3% | - | -873.9% | |
| VRTX | $12.0B | +10.4% | +14.1% | 39.1% | |
| ASND | $692M | +97.4% | +150.9% | -18.9% | |
| BBIO | $502M | +126.3% | +127.4% | -113.3% | |
| BMRN | $3.2B | +12.9% | - | 16.6% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $868.5M | +21.5% | $670.1M | 77.2% | $208.5M | 24.0% |
| 2024 | $714.7M | +22.8% | $557.9M | 78.1% | $190.8M | 26.7% |
| 2023 | $582.0M | +32.9% | $460.8M | 79.2% | $192.0M | 33.0% |
| 2022 | $437.9M | +43.4% | $354.4M | 80.9% | $120.2M | 27.4% |
| 2021 | $305.4M | +91.2% | $249.9M | 81.8% | $87.5M | 28.7% |
| 2020 | $159.7M | +2564.6% | $132.0M | 82.6% | $17.0M | 10.6% |
| 2019 | $6.0M | - | $4.4M | 73.7% | $-145,904,000 | -2433.8% |
| 2018 | $0 | - | $-184,000 | - | $-41,439,000 | - |
See HRMY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HRMY Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare HRMY vs AGIO
See how HRMY stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is HRMY's revenue growth accelerating or slowing?
HRMY revenue is accelerating at +21.1% year-over-year, exceeding the 5-year CAGR of +40.3%. TTM revenue reached $868M. Growth momentum has increased versus prior periods.
What is HRMY's long-term revenue growth rate?
Harmony Biosciences Holdings, Inc.'s 5-year revenue CAGR of +40.3% reflects the sustained expansion pattern. Current YoY growth of +21.1% is above this long-term average.
How is HRMY's revenue distributed by segment?
HRMY reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.